Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jacobi

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Journal of the American College of Cardiology|April 13, 2001
Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeksS John, C Delles, J Jacobi, et al.
American Journal of Hypertension|September 12, 2000
Enhanced antinatriuresis in response to angiotensin II in essential hypertensionA U Klingbeil, J Jacobi, M R Langenfeld, et al.
Journal of the American College of Cardiology|January 12, 2001
Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humansR E Schmieder, J Erdmann, C Delles, et al.
Drug Intelligence & Clinical Pharmacy|April 1, 1982
Loss of nitroglycerin to central venous pressure catheterJ Jacobi, J F Dasta, L S Wu, et al.
Kidney International|April 28, 2006
Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in ratsJ Jacobi, M Porst, N Cordasic, et al.
Journal of the American College of Cardiology|November 6, 2001
Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertensionC Delles, J Erdmann, J Jacobi, et al.
Transplantation|September 26, 2000
Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantationJ Jacobi, J Rockstroh, S John, et al.
Clinical Nephrology|March 3, 2004
The presence of erythropoietin receptors in the human peripheral nervous systemK Hassan, B Gross, W Simri, et al.
Critical Care Medicine|January 1, 1983
Loss of nitroglycerin to cardiopulmonary bypass apparatusJ F Dasta, J Jacobi, L S Wu, et al.
Molecular Cancer Research : MCR|September 27, 2022
JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted TherapySpencer R Rosario, Justine J Jacobi, Mark D Long, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Journal of the American College of Cardiology|April 13, 2001
Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeksS John, C Delles, J Jacobi, et al.
American Journal of Hypertension|September 12, 2000
Enhanced antinatriuresis in response to angiotensin II in essential hypertensionA U Klingbeil, J Jacobi, M R Langenfeld, et al.
Journal of the American College of Cardiology|January 12, 2001
Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humansR E Schmieder, J Erdmann, C Delles, et al.
Drug Intelligence & Clinical Pharmacy|April 1, 1982
Loss of nitroglycerin to central venous pressure catheterJ Jacobi, J F Dasta, L S Wu, et al.
Kidney International|April 28, 2006
Subtotal nephrectomy impairs ischemia-induced angiogenesis and hindlimb re-perfusion in ratsJ Jacobi, M Porst, N Cordasic, et al.
Journal of the American College of Cardiology|November 6, 2001
Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertensionC Delles, J Erdmann, J Jacobi, et al.
Transplantation|September 26, 2000
Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantationJ Jacobi, J Rockstroh, S John, et al.
Clinical Nephrology|March 3, 2004
The presence of erythropoietin receptors in the human peripheral nervous systemK Hassan, B Gross, W Simri, et al.
Critical Care Medicine|January 1, 1983
Loss of nitroglycerin to cardiopulmonary bypass apparatusJ F Dasta, J Jacobi, L S Wu, et al.
Molecular Cancer Research : MCR|September 27, 2022
JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted TherapySpencer R Rosario, Justine J Jacobi, Mark D Long, et al.
Pageof 10